$174 Million is the total value of Arboretum Ventures, Inc.'s 3 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | EQRX INC | $95,041,000 | – | 13,935,623 | +100.0% | 54.75% | – | |
| New | PEAR THERAPEUTICS INC | $67,326,000 | – | 10,859,050 | +100.0% | 38.78% | – | |
| INGN | New | INOGEN INC | $11,220,000 | – | 330,000 | +100.0% | 6.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| EQRX INC | 5 | Q4 2022 | 72.6% |
| PEAR THERAPEUTICS INC | 5 | Q4 2022 | 44.6% |
| INOGEN INC | 5 | Q4 2022 | 12.1% |
View Arboretum Ventures, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-01-25 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-07-22 |
| 13F-HR | 2022-05-11 |
| 13F-HR | 2022-02-09 |
View Arboretum Ventures, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.